Lifastuzumab vedotin
Product Specifications
CAS Number
1401812-88-1
Synonyms
LIFA, DNIB0600A, RG-7599
SKU
C00970-1mg
Target
Sodium Channel
Applications
Transmembrane Transporters
Additionnal Information
Lifastuzumab vedotin (LIFA, DNIB0600A, RG-7599) is an antibody-drug conjugate (ADC) composed of a humanized anti-NaPi2b monoclonal antibody and an anti-mitotic cytotoxic agent, monomethyl auristatin E (MMAE) . Lifastuzumab vedotin is used in the treatment of platinum-resistant ovarian cancer.
Storage Conditions
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1437235-01 0.02 mg (E-Coli)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details MBS1437235-02 0.02 mg (Yeast)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details 
MBS1437235-03 0.1 mg (E-Coli)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details MBS1437235-04 0.1 mg (Yeast)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details MBS1437235-05 0.02 mg (Baculovirus)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details MBS1437235-06 0.02 mg (Mammalian-Cell)
Recombinant Lactobacillus acidophilus UPF0348 protein LBA1527 (LBA1527)
Ask
View Details